Cell stress molecules in the skeletal muscle of GNE myopathy

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Fischer, Charlotte ^a   Kleinschnitz, Konstanze ^a,b   Wrede, Arne ^a   Muth, Ingrid ^a   Kruse, Niels ^a,b   Nishino, Ichizo ^c   Schmidt, Jens ^a,b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Gemeinnutzige Hertie Stiftung   (Germany)

^c NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

B crystallin; Cell stress; Myopathy; Nitric oxide; Skeletal muscle pathology

Indexed keywords

ALPHA CRYSTALLIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; EOSIN; HEMATOXYLIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE 2 EPIMERASE;

ADULT; ARTICLE; CELL STRESS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GNE MYOPATHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MUSCLE BIOPSY; MUSCLE CELL; MYOPATHY; NEUROFILAMENT; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SKELETAL MUSCLE; UPREGULATION;

ADULT; ALPHA-CRYSTALLIN B CHAIN; AMYLOID BETA-PROTEIN PRECURSOR; ARABIDOPSIS PROTEINS; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTRAMOLECULAR TRANSFERASES; MALE; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUTATION; NEURAL CELL ADHESION MOLECULES; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84874795550     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-24     Document Type: Article

References (27)

1. Argov Z, Yarom R. "Rimmed vacuole myopathy" sparing the quadriceps. A unique disorder in Iranian Jews. J Neurol Sci 1984, 64:33-43. 10.1016/0022-510X(84)90053-4, 6737002.
2. Sadeh M, Gadoth N, Hadar H, Ben David E. Vacuolar myopathy sparing the quadriceps. Brain 1993, 116:217-232. 10.1093/brain/116.1.217, 8453459.
3. Nonaka I, Noguchi S, Nishino I. Distal myopathy with rimmed vacuoles and hereditary inclusion body myopathy. Curr Neurol Neurosci Rep 2005, 5:61-65. 10.1007/s11910-005-0025-0, 15676110.
4. Broccolini A, Gidaro T, Morosetti R, Mirabella M. Hereditary inclusion-body myopathy: clues on pathogenesis and possible therapy. Muscle Nerve 2009, 40:340-349. 10.1002/mus.21385, 19618441.
5. Sparks S, Rakocevic G, Joe G, Manoli I, Shrader J, Harris-Love M, Sonies B, Ciccone C, Dorward H, Krasnewich D, Huizing M, Dalakas MC, Gahl WA. Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study. BMC Neurol 2007, 7:3. 1790898, 17261181.
6. Nemunaitis G, Maples PB, Jay C, Gahl WA, Huizing M, Poling J, Tong AW, Phadke AP, Pappen BO, Bedell C, Templeton NS, Kuhn J, Senzer N, Nemunaitis J. Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapy. J Gene Med 2010, 12:403-412. 10.1002/jgm.1450, 20440751.
7. Nishino I, Malicdan MC, Murayama K, Nonaka I, Hayashi YK, Noguchi S. Molecular pathomechanism of distal myopathy with rimmed vacuoles. Acta Myol 2005, 24:80-83.
8. Eisenberg I, Avidan N, Potikha T, Hochner H, Chen M, Olender T, Barash M, Shemesh M, Sadeh M, Grabov-Nardini G, Shmilevich I, Friedmann A, Karpati G, Bradley WG, Baumbach L, Lancet D, Asher EB, Beckmann JS, Argov Z, Mitrani-Rosenbaum S. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001, 29:83-87. 10.1038/ng718, 11528398.
9. Malicdan MC, Noguchi S, Nonaka I, Hayashi YK, Nishino I. A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum Mol Genet 2007, 16:2669-2682. 10.1093/hmg/ddm220, 17704511.
10. Noguchi S, Keira Y, Murayama K, Ogawa M, Fujita M, Kawahara G, Oya Y, Imazawa M, Goto Y, Hayashi YK, Nonaka I, Nishino I. Reduction of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase activity and sialylation in distal myopathy with rimmed vacuoles. J Biol Chem 2004, 279:11402-11407. 10.1074/jbc.M313171200, 14707127.
11. Schmidt J, Barthel K, Wrede A, Salajegheh M, Bahr M, Dalakas MC. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle. Brain 2008, 131:1228-1240. 2367696, 18420712.
12. Muth IE, Barthel K, Bahr M, Dalakas MC, Schmidt J. Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid. J Neurol Neurosurg Psychiatry 2009, 80:1344-1349. 10.1136/jnnp.2009.174276, 19470495.
13. Schmidt J, Barthel K, Zschuntzsch J, Muth IE, Swindle EJ, Hombach A, Sehmisch S, Wrede A, Luhder F, Gold R, Dalakas MC. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1beta-induced accumulation of beta-amyloid and cell death. Brain 2012, 135:1102-1114. 10.1093/brain/aws046, 22436237.
14. Kleinert H, Pautz A, Linker K, Schwarz PM. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 2004, 500:255-266. 10.1016/j.ejphar.2004.07.030, 15464038.
15. Bastian A, Goebel HH. Protein aggregation in inclusion body myositis, a sporadic form among protein aggregate myopathies, and in myofibrillar myopathies-a comparative study. Rom J Intern Med 2010, 48:377-384.
16. Yang CC, Alvarez RB, Engel WK, Heller SL, Askanas V. Nitric oxide-induced oxidative stress in autosomal recessive and dominant inclusion-body myopathies. Brain 1998, 121:1089-1097. 10.1093/brain/121.6.1089, 9648544.
17. Banwell BL, Engel AG. alpha B-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 2000, 54:1033-1041. 10.1212/WNL.54.5.1033, 10720271.
18. Goldfarb LG, Vicart P, Goebel HH, Dalakas MC. Desmin myopathy. Brain 2004, 127:723-734. 10.1093/brain/awh033, 14724127.
19. Fonte V, Kipp DR, Yerg J, Merin D, Forrestal M, Wagner E, Roberts CM, Link CD. Suppression of in vivo beta-amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein. J Biol Chem 2008, 283:784-791. 10.1074/jbc.M703339200, 17993648.
20. Wilhelmus MM, Boelens WC, Otte-Holler I, Kamps B, de Waal RM, Verbeek MM. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Brain Res 2006, 1089:67-78. 10.1016/j.brainres.2006.03.058, 16635482.
21. Wojcik S, Engel WK, McFerrin J, Paciello O, Askanas V. AbetaPP-overexpression and proteasome inhibition increase alphaB-crystallin in cultured human muscle: relevance to inclusion-body myositis. Neuromuscul Disord 2006, 16:839-844. 10.1016/j.nmd.2006.08.009, 1976411, 17056255.
22. Ferrer I, Martin B, Castano JG, Lucas JJ, Moreno D, Olive M. Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. J Neuropathol Exp Neurol 2004, 63:484-498.
23. Tews DS, Goebel HH. Cell death and oxidative damage in inflammatory myopathies. Clin Immunol Immunopathol 1998, 87:240-247. 10.1006/clin.1998.4527, 9646833.
24. Wanchu A, Khullar M, Sud A, Bambery P. Nitric oxide production is increased in patients with inflammatory myositis. Nitric Oxide 1999, 3:454-458. 10.1006/niox.1999.0261, 10637123.
25. De Paepe B, Racz GZ, Schroder JM, De Bleecker JL. Expression and distribution of the nitric oxide synthases in idiopathic inflammatory myopathies. Acta Neuropathol (Berl) 2004, 108:37-42.
26. Tateyama M, Takeda A, Onodera Y, Matsuzaki M, Hasegawa T, Nunomura A, Hirai K, Perry G, Smith MA, Itoyama Y. Oxidative stress and predominant A beta 42(43) deposition in myopathies with rimmed vacuoles. Acta Neuropathol (Berl) 2003, 105:581-585.
27. Malicdan MC, Noguchi S, Hayashi YK, Nonaka I, Nishino I. Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 2009, 15:690-695. 10.1038/nm.1956, 19448634.